Technical Analysis for CRTX - Cortexyme, Inc.

Grade Last Price % Change Price Change
grade C 41.49 0.46% 0.19
CRTX closed up 0.46 percent on Monday, July 15, 2019, on 39 percent of normal volume.
0 Watchers
View Intraday Alerts Watchlist Portfolio

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A N/A Up
See historical CRTX trend table...

Date Alert Name Type % Chg
Inside Day Range Contraction 0.46%
Multiple of Ten Bullish Other -0.60%
Wide Bands Range Expansion -0.60%
Up 3 Days in a Row Strength -0.60%
Up 4 Days in a Row Strength -0.60%
Multiple of Ten Bullish Other 2.19%
Wide Bands Range Expansion 2.19%
Up 3 Days in a Row Strength 2.19%
20 DMA Support Bullish 2.42%
1,2,3 Pullback Bullish Bullish Swing Setup 2.42%

Older signals for CRTX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Analyze My Stocks!
Configure default chart indicators
Basic chart:
Profile
Cortexyme is a clinical stage pharmaceutical company pioneering a novel disease-modifying therapeutic approach to treat a key underlying cause of Alzheimer's disease and other degenerative diseases. Cortexyme is targeting a specific, infectious pathogen found in the brain of Alzheimer’s patients and tied to neurodegeneration and neuroinflammation in animal models. The company's lead investigational medicine, COR388, is the subject of the GAIN Trial, an ongoing Phase 2/3 clinical study in patients with mild to moderate Alzheimer’s.
Medical Specialties Organ Systems Alzheimer's Disease Nervous System Neurology Degenerative Diseases Stage Pharmaceutical
Is CRTX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 0 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Date Title
Jul 12 Key events next week - healthcare
Jul 10 Cortexyme Announces Upcoming Data Presentations at the Alzheimer’s Association International Conference 2019
Jul 5 These Bay Area companies are part of an uptick in women-led IPOs
Jul 1 A Halftime Report Of The IPO Market In 2019
Jul 1 Here are big Bay Area winners, losers from busy first half of IPOs
Jun 26 Cortexyme's unique approach to Alzheimer's research
Jun 20 Arbutus Biopharma leads healthcare gainers; Verastem and Jaguar Health among losers
Jun 19 Cortexyme Expands Clinical Advisory Board With Key Clinical and Regulatory Experts
Jun 18 SPWR, GCP, TDS and BHVN among midday movers
Jun 14 Cortexyme: Valued On Skepticism
See more CRTX news...
Indicators
Indicator Value
52 Week High 47.5
52 Week Low 19.5
Average Volume 115,879
200-Day Moving Average 0.0
50-Day Moving Average 0.0
20-Day Moving Average 39.6995
10-Day Moving Average 40.626
Average True Range 3.1744
ADX 36.76
+DI 25.6862
-DI 12.9017
Chandelier Exit (Long, 3 ATRs ) 37.9768
Chandelier Exit (Short, 3 ATRs ) 37.2032
Upper Bollinger Band 44.4194
Lower Bollinger Band 34.9796
Percent B (%b) 0.69
BandWidth 23.778133
MACD Line 2.8038
MACD Signal Line 3.0398
MACD Histogram -0.236
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 44.37
Resistance 3 (R3) 44.19 43.06 43.89
Resistance 2 (R2) 43.06 42.32 43.15 43.73
Resistance 1 (R1) 42.27 41.87 42.67 42.45 43.57
Pivot Point 41.14 41.14 41.33 41.23 41.14
Support 1 (S1) 40.35 40.40 40.75 40.53 39.41
Support 2 (S2) 39.22 39.95 39.31 39.25
Support 3 (S3) 38.43 39.22 39.09
Support 4 (S4) 38.61